Global manufacturers like Nestlé Health Science and Danone are increasingly focusing on the development of savory and plant-based options to meet diverse patient preferences. This strategic pivot comes at a time when the trauma recovery nutrition market is undergoing a significant transformation,
By adopting a flexible modular design, Bayer is engineering a manufacturing environment capable of adapting to the rapid evolution of therapeutic drug requirements. This strategic $2.2 billion commitment to establish a state-of-the-art pharmaceutical campus in New Albany, Ohio, marks a significant
The Italian CDMO sector has seen its export turnover quadruple over the last ten years, signaling a profound shift in the continent’s industrial power balance. This evolution has transformed Italy into the central pillar of the European pharmaceutical landscape, particularly through the excellence
The metabolic fitness of manufactured immune cells is a crucial metric, as exhausted cells lose their ability to persist once injected into a patient. Glioblastoma multiforme remains a relentless adversary in the field of neuro-oncology, characterized by its rapid progression and an almost
Clinical investigators are utilizing the follicle-stimulating hormone itself as a targeting mechanism to guide engineered T-cells directly to the FSHR-expressing ovarian tumor cells. This innovative approach, known as liraltagene autoleucel or lira-cel, represents a pivotal shift in how oncologists
The inaugural Singapore Engineering Biology Week in October 2026 will showcase the nation’s progress in research translation and the bioeconomy. This landmark event serves as the backdrop for the unveiling of the National Centre for Engineering Biology, a specialized facility hosted at the National
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42